Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PAX6 mutations reviewed

J Prosser1, V van Heyningen

  • 1MRC Human Genetics Unit, Western General Hospital, Edinburgh, UK.

Human Mutation
|March 3, 1998
PubMed
Summary
This summary is machine-generated.

Mutations in the PAX6 gene cause aniridia and other eye conditions. Most PAX6 mutations lead to a loss of gene function, impacting eye development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying the Most Clinically Effective Exercise Prescription for Improving Maximum Walking Distance in People with Intermittent Claudication: A Systematic Review with Network and Component Network Meta-analysis.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2026
Same author

Infant botulism due to C. butyricum type E toxin: a novel environmental association with pet terrapins.

Epidemiology and infection·2014
Same author

An ordered sequence of expression of human MHC class-II antigens during B-cell maturation?

Immunology today·2014
Same author

Further intricacy of HLA-DR antigens.

Immunology today·2014
Same author

Mobility and survival of Salmonella Typhimurium and human adenovirus from spiked sewage sludge applied to soil columns.

Journal of applied microbiology·2009
Same author

FISH mapping of de novo apparently balanced chromosome rearrangements identifies characteristics associated with phenotypic abnormality.

American journal of human genetics·2008
Same journal

RETRACTION: "Differential Effects of AKT1(p.E17K) Expression on Human Mammary Luminal Epithelial and Myoepithelial Cells".

Human mutation·2026
Same journal

Diagnostic Yield of Genome Sequencing in an Iranian Exome-Negative Autosomal-Recessive Intellectual Disability Cohort.

Human mutation·2026
Same journal

Exploring the Functional Impact of Individual <i>DDX41</i> Variants With a Fast and Robust Cell-Based Method.

Human mutation·2026
Same journal

Modeling the Effects of Single Nucleotide Polymorphisms (SNPs) on the Structure and Function of the Human <i>RET</i> Gene: An In Silico Study.

Human mutation·2026
Same journal

Driver Mutation Subtypes Differentially Shape Immune Evasion Landscapes in Melanoma: An AI-Driven Inflammatory Pathway Model Implicating CCNE1.

Human mutation·2026
Same journal

Comment on "When the Outcome Contains the Exposure: Methodological Limits of a Genome-Wide Cross-Trait Analysis of Type 2 Diabetes and MASLD".

Human mutation·2026
See all related articles

Area of Science:

  • Genetics
  • Ophthalmology
  • Developmental Biology

Background:

  • Mutations in the PAX6 gene are the primary cause of human aniridia.
  • PAX6 mutations are also associated with Peter's anomaly, congenital cataracts, autosomal dominant keratitis, and foveal hypoplasia.
  • The PAX6 gene, located at chromosome 11p13, is considered the major gene responsible for aniridia.

Purpose of the Study:

  • To analyze the spectrum and characteristics of PAX6 mutations.
  • To understand the mutation patterns within the PAX6 gene.
  • To investigate the functional consequences of identified PAX6 mutations.

Main Methods:

  • Review and analysis of reported PAX6 mutations.
  • Categorization of mutations based on type (e.g., C-T changes, splicing errors, deletions/insertions).

Related Experiment Videos

  • Assessment of mutation distribution within different gene domains (paired and homeodomain).
  • Main Results:

    • C-T changes at CpG dinucleotides (28%) and splicing errors (20%) are common PAX6 mutation types.
    • Over 30% of mutations involve deletions or insertions.
    • Elevated mutation rates are observed in the paired domain, with increased mutations in the homeodomain due to a hypermutable CpG dinucleotide.
    • The majority of mutations result in a loss of function, with over 80% of exonic substitutions leading to nonsense codons.

    Conclusions:

    • PAX6 mutations are strongly linked to aniridia and related eye disorders.
    • Specific mutation types and hotspots (CpG dinucleotides) are identified within the PAX6 gene.
    • Most PAX6 mutations identified result in a loss of protein function, explaining the associated phenotypes.
    • Undiscovered missense mutations in highly conserved regions may contribute to unidentified ocular phenotypes.